Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: A retrospective study

被引：0
|
作者：
Li, Rongrong
Zhou, Hui-Jun
Zeng, De-Yu
Jiang, Shao-Feng
Liu, Wu
Liu, Zhen-yang
机构：
[1] Cent South Univ, Dept Med Oncol Gastroenterol & Urol, Hunan Canc Hosp, Affiliated Canc Hosp,Xiangya Sch Med, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Dept Gastroenterol & Urol,Hunan Canc Hosp, Changsha, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15562
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of trifluridine/tipiracil plus bevacizumab across different subgroups of patients with refractory colorectal cancer: a meta-analysis
    Leite da Silva, Luis Felipe
    Saldanha, Erick Figueiredo
    da Conceicao, Lucas Diniz
    Martins, Wolney de Andrade
    Gismondi, Ronaldo Altenburg
    de Souza Filho, Erito Marques
    Peixoto, Renata D'Alpino
    ECANCERMEDICALSCIENCE, 2024, 18
  • [32] A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer
    Zou, Jiayun
    Wang, Yuanyuan
    Xu, Jiayu
    Li, Jinna
    Wang, Tianzhuo
    Zhang, Ying
    Bai, Yibo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [33] Randomized study evaluating trifluridine/tipiracil (TAS-102) versus + trifluridine/tipiracil plus bevacizumab as last-line therapy in patients with chemorefractory unresectable metastatic colorectal cancer (mCRC).
    Pfeiffer, Per
    Yilmaz, Mette
    Moller, Soren
    Maltha, Line
    Krogh, Merete
    Zitnjak, Daniela
    Szameitat, Caroline Lemb
    Hejlesen, Finn
    Thomsen, Karina Gravgaard
    Qvortrup, Camilla
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [34] Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution
    Kotani, Daisuke
    Shitara, Kohei
    Kawazoe, Akihito
    Fukuoka, Shota
    Kuboki, Yasutoshi
    Bando, Hideaki
    Okamoto, Wataru
    Kojima, Takashi
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yoshino, Takayuki
    CLINICAL COLORECTAL CANCER, 2016, 15 (03) : E109 - E115
  • [35] Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey
    Ozet, Ahmet
    Dane, Faysal
    Aykan, Nuri Faruk
    Yalcin, Suayib
    Evrensel, Turkkan
    Ozkan, Metin
    Karabulut, Bulent
    Ormeci, Merve Nur
    Atasev, Ozan
    Vidot, Loick
    Cicin, Irfan
    FUTURE ONCOLOGY, 2022, 18 (29) : 3267 - 3276
  • [36] Neutropenia in metastatic colorectal cancer receiving trifluridine/tipiracil
    Colloca, G.
    Venturino, A.
    Guarneri, D.
    ANNALS OF ONCOLOGY, 2020, 31 (07) : 958 - 958
  • [37] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Yoshiaki Fujimoto
    Ryota Nakanishi
    Mamoru Nukatsuka
    Kazuaki Matsuoka
    Koji Ando
    Takeshi Wakasa
    Hiroyuki Kitao
    Eiji Oki
    Yoshihiko Maehara
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1029 - 1038
  • [38] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Fujimoto, Yoshiaki
    Nakanishi, Ryota
    Nukatsuka, Mamoru
    Matsuoka, Kazuaki
    Ando, Koji
    Wakasa, Takeshi
    Kitao, Hiroyuki
    Oki, Eiji
    Maehara, Yoshihiko
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1029 - 1038
  • [39] Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G)
    Kito, Yosuke
    Kawakami, Hisato
    Mitani, Seiichiro
    Nishina, Shinichi
    Matsumoto, Toshihiko
    Tsuzuki, Takao
    Shinohara, Yudai
    Shimokawa, Hozumi
    Kumanishi, Ryosuke
    Ohta, Takashi
    Katsuya, Hiroo
    Kawakami, Takeshi
    Nishina, Tomohiro
    Hasegawa, Hiroko
    Akiyoshi, Kohei
    Chiba, Yasutaka
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Muro, Kei
    ONCOLOGIST, 2024, 29 (03): : E330 - E336
  • [40] Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study
    Garcia-Alfonso, Pilar
    Munoz, Andres
    Jimenez-Castro, Jeronimo
    Jimenez-Fonseca, Paula
    Pericay, Carles
    Longo-Munoz, Federico
    Reyna-Fortes, Carmen
    Argiles-Martinez, Guillem
    Gonzalez-Astorga, Beatriz
    Jose Gomez-Reina, Maria
    Ruiz-Casado, Ana
    Rodriguez-Salas, Nuria
    Lopez-Lopez, Rafael
    Carmona-Bayonas, Alberto
    Conde-Herrero, Veronica
    Aranda, Enrique
    CANCERS, 2021, 13 (18)
12345